Levosalbutamol Completed Phase 3 Trials for Asthma Bronchial Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02414854Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)
NCT02528214Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma
NCT00064389Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma
NCT00073827Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
NCT00073814Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
NCT00073840Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
NCT00667407Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma
NCT00809757A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma